The agency approved the first over-the-counter continuous glucose monitor, known as Stelo, for adults with diabetes who do ...

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

Continuous glucose monitoring, compared with fingerstick tests, was feasible and accurate in an inpatient setting among patients and nurses.

Continuous Glucose Monitoring (CGM) Systems Market The increasing incidence of diabetes and the detection of patient's blood glucose levels are raising the demand for continuous global monitoring ...

St. Louis-based diabetes treatment startup Aegis Digital Health is nearing $1 million in its latest funding round and seeing ...

A top nutrition researcher said blood sugar monitoring helped her solve her afternoon exhaustion by switching to a new ...

Remote patient monitoring has exploded since the pandemic. In just four years from the beginning of 2019 through 2022, ...

The FDA cleared Eversense 365 as the first 1-year integrated continuous glucose monitoring (CGM) system for adults with type ...

Biosensors that measure glucose are now available without a prescription. Wearing one burst my wellness bubble in ways I wasn ...

DUBLIN, Sept. 18, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today ...

Implementation of continuous glucose monitoring (CGM ... The researchers also administered a System Usability Scale questionnaire to nurses who engaged with the CGM policy, whereas patients ...